AMR Industry Alliance 2020 Progress Report

Perceptions and recommendations of physicians/KOLs on value added medicines

The secret to improve access to value added medicines

Overarching recommendations for improved access to generic and biosimilar medicines in the hospital setting

Improving healthcare delivery in hospitals by optimized utilization of medicines

A digital future for value added medicines

Open letter to the Members of the European Parliament on the importance to sustain EU progress in fighting against antimicrobial resistance (AMR)

Medicines for Europe Commentary on the Draft EMA regulatory science strategy 2025

How can your healthcare system support a wider access to Value Added Medicines?

Annual Medicines for Europe and IGBA Conference 2019